This article is published in association with United Nations. The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines, marking a significant shift in global health policy as obesity rates continue to rise.  The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and […]